Prognosis
France Won’t Delay Second Covid Vaccine Dose, Citing Risks From New Variants
- Health authority had recommended delay to immunize more
- Officials point to lack of consensus and risk of new variants
France will administer the second dose of the Pfizer-BioNTech vaccine within 21 to 28 days of the first.
Photographer: Nathan Laine/BloombergThis article is for subscribers only.
France decided not to delay second doses of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE, shunning the advice of its health authority and citing risks and uncertainties in the face of new variants.
“We are facing a degree of unknown and uncertainty,” Health Minister Olivier Veran said Tuesday at a press conference in Paris. “There’s a lack of scientific consensus. So I’m making a choice based on validated data that we fully understand.”